Showing results (21-30 of 486) with videos related to
Sort By:
Pageof 49
Blood|April 25, 2022
Inflammation and myeloid malignancy: quenching the flameRyan J Stubbins, Uwe Platzbecker, Aly KarsanBlood|January 4, 2019
Luspatercept for the treatment of anemia in myelodysplastic syndromes and primary myelofibrosisPierre Fenaux, Jean Jacques Kiladjian, Uwe PlatzbeckerLeukemia|May 11, 2018
Management of patients with acute promyelocytic leukemiaSabine Kayser, Richard F Schlenk, Uwe PlatzbeckerHemasphere|February 3, 2025
Diagnosis and treatment of AML in the context of WHO and ICC 2022 classifications: Divergent nomenclature converges on common therapiesUwe Platzbecker, Richard A Larson, Sandeep GurbuxaniClinical Lymphoma, Myeloma & Leukemia|November 16, 2020
Allogeneic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes and Prevention of RelapseGeorg-Nikolaus Franke, Philipp Lückemeier, Uwe PlatzbeckerJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2020
Integrating the "Immunome" in the Stratification of Myelodysplastic Syndromes and Future Clinical Trial DesignSusann Winter, Saeed Shoaie, Shahram Kordasti, et al.Expert Review of Clinical Immunology|May 19, 2010
Stem cell transplantation for patients with Evans syndromeMartin Benesch, Christian Urban, Uwe Platzbecker, et al.Genes|January 8, 2025
MicroRNA Screening Reveals Upregulation of FoxO-Signaling in Relapsed Acute Myeloid Leukemia PatientsPaula Reichelt, Stephan Bernhart, Uwe Platzbecker, et al.British Journal of Haematology|July 25, 2003
Chelerythrin activates caspase-8, downregulates FLIP long and short, and overcomes resistance to tumour necrosis factor-related apoptosis-inducing ligand in KG1a cellsUwe Platzbecker, Jessica L Ward, H Joachim DeegExpert Review of Hematology|November 15, 2011
Optimizing management of myelodysplastic syndromes post-allogeneic transplantationKatja Sockel, Gerhard Ehninger, Lorenz C Hofbauer, et al.Pageof 49